Paul L. Weiden

10.0k total citations · 3 hit papers
105 papers, 7.6k citations indexed

About

Paul L. Weiden is a scholar working on Hematology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Paul L. Weiden has authored 105 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Hematology, 26 papers in Pulmonary and Respiratory Medicine and 25 papers in Genetics. Recurrent topics in Paul L. Weiden's work include Hematopoietic Stem Cell Transplantation (33 papers), Virus-based gene therapy research (21 papers) and Radiopharmaceutical Chemistry and Applications (14 papers). Paul L. Weiden is often cited by papers focused on Hematopoietic Stem Cell Transplantation (33 papers), Virus-based gene therapy research (21 papers) and Radiopharmaceutical Chemistry and Applications (14 papers). Paul L. Weiden collaborates with scholars based in United States, South Africa and Germany. Paul L. Weiden's co-authors include Rainer Storb, E. Donnall Thomas, Keith M. Sullivan, Howard M. Shulman, George E. Sale, Mang-So Tsoi, Robert C. Hackman, Gary E. Striker, George B. McDonald and Nancy Flournoy and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Investigation.

In The Last Decade

Paul L. Weiden

104 papers receiving 7.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chronic graft-versus-host syndrome in man

1980 1.9k citations Howard M. Shulman, Keith M. Sullivan et al. profile →
Antileukemic Effect of Chronic Graft-versus-Host Disease

1981 849 citations Paul L. Weiden, Keith M. Sullivan et al. New England Journal of Medicine profile →
Marrow Transplantation for Acute Nonlymphoblastic Leukemia in First Remission

1979 454 citations E. Donnall Thomas, George E. Sale et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul L. Weiden United States	36	5.1k	2.4k	1.7k	1.0k	982	105	7.6k
F R Appelbaum United States	47	6.0k 1.2×	1.9k 0.8×	2.9k 1.7×	763 0.7×	1.2k 1.2×	99	8.5k
P Beatty United States	33	6.9k 1.4×	3.8k 1.6×	2.0k 1.2×	817 0.8×	1.2k 1.2×	68	9.6k
George E. Sale United States	37	4.5k 0.9×	2.1k 0.9×	1.7k 1.0×	411 0.4×	1.1k 1.1×	97	7.4k
Clift Ra United States	40	6.0k 1.2×	1.5k 0.6×	1.7k 1.0×	411 0.4×	1.6k 1.6×	100	7.2k
Robert P. Witherspoon United States	48	5.7k 1.1×	2.3k 1.0×	2.1k 1.2×	357 0.3×	1.2k 1.3×	104	8.0k
Thomas Ed United States	55	8.2k 1.6×	2.9k 1.2×	3.1k 1.8×	561 0.5×	2.0k 2.0×	223	10.8k
Rainer Storb United States	34	6.6k 1.3×	2.9k 1.2×	1.9k 1.1×	294 0.3×	1.1k 1.2×	104	8.6k
C. Dean Buckner United States	36	8.4k 1.6×	3.5k 1.5×	2.7k 1.6×	402 0.4×	1.5k 1.5×	95	10.4k
FR Appelbaum United States	63	9.3k 1.8×	3.4k 1.5×	3.4k 2.0×	866 0.8×	2.0k 2.0×	189	12.4k
K Doney United States	55	8.7k 1.7×	2.9k 1.2×	2.6k 1.5×	465 0.4×	1.7k 1.7×	142	10.6k

Countries citing papers authored by Paul L. Weiden

Since Specialization

Citations

This map shows the geographic impact of Paul L. Weiden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul L. Weiden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul L. Weiden more than expected).

Fields of papers citing papers by Paul L. Weiden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul L. Weiden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul L. Weiden. The network helps show where Paul L. Weiden may publish in the future.

Co-authorship network of co-authors of Paul L. Weiden

This figure shows the co-authorship network connecting the top 25 collaborators of Paul L. Weiden. A scholar is included among the top collaborators of Paul L. Weiden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul L. Weiden. Paul L. Weiden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Muntz, Howard G., et al.. (2008). Phase 2 study of intraperitoneal topotecan as consolidation chemotherapy in ovarian and primary peritoneal carcinoma. Cancer. 113(3). 490–496. 6 indexed citations

Bogdanova, Natalia, et al.. (2004). Paclitaxel injectable emulsion: Phase 2a study of weekly administration in patients with non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 22(14_suppl). 7133–7133. 4 indexed citations

Weiden, Paul L.. (2002). Pretargeted Radioimmunotherapy (PRIT™) Using an Antibody-Streptavidin Fusion Protein in Non-Hodgkin's Lymphoma. Leukemia & lymphoma. 43(10). 1971–1973. 6 indexed citations

Breitz, Hazel B., Paul L. Weiden, Paul L. Beaumier, et al.. (2000). Clinical optimization of pretargeted radioimmunotherapy with antibody-streptavidin conjugate and 90Y-DOTA-biotin.. PubMed. 41(1). 131–40. 124 indexed citations

Gopal, Ajay K., Scott M. Schuetze, David G. Maloney, & Paul L. Weiden. (1999). Large cell non-Hodgkin's lymphoma and Hodgkin's disease arising synchronously in a patient with chronic lymphocytic leukemia: importance of immunocytochemistry.. Blood. 94(7). 2537–2537. 9 indexed citations

Weiden, Paul L., et al.. (1997). Concomitant Intraarterial Cisplatin, Intravenous 5-Fluorouracil, and Split-Course Radiation Therapy for Locally Advanced Unresectable Pancreatic Adenocarcinoma: A Phase II Study of the Puget Sound Oncology Consortium (PSOC-703). American Journal of Clinical Oncology. 20(2). 161–165. 16 indexed citations

Weiden, Paul L., Hazel B. Breitz, M J Bjorn, et al.. (1993). Rhenium-186-labeled chimeric antibody NR-LU-13: pharmacokinetics, biodistribution and immunogenicity relative to murine analog NR-LU-10.. PubMed. 34(12). 2111–9. 24 indexed citations

Mortimer, Joanne, John Crowley, Harmon J. Eyre, et al.. (1992). A phase II randomized study comparing sequential and combined intraarterial cisplatin and radiation therapy in primary brain tumors: A southwest oncology group study. Cancer. 69(5). 1220–1223. 32 indexed citations

Weiden, Paul L.. (1990). Do perioperative blood transfusions increase the risk of cancer recurrence?. European Journal of Cancer and Clinical Oncology. 26(9). 987–989. 9 indexed citations

10.

Buckner, CD, Frederick R. Appelbaum, Patricia Stewart, et al.. (1987). Marrow transplantation for acute nonlymphocytic leukemia following therapy for Hodgkin's disease.. Journal of Clinical Oncology. 5(5). 731–734. 25 indexed citations

11.

Deeg, H. Joachim, F R Appelbaum, Paul L. Weiden, et al.. (1985). Autologous marrow transplantation as consolidation therapy for canine lymphoma: Efficacy and toxicity of various regimens of total body irradiation. American Journal of Veterinary Research. 46(9). 2016–2018. 25 indexed citations

12.

Weiden, Paul L.. (1984). Graft-v-Host Disease Following Blood Transfusions. Archives of Internal Medicine. 144(8). 1557–1557. 12 indexed citations

13.

Weiden, Paul L., et al.. (1981). Antileukemic Effect of Chronic Graft-versus-Host Disease. New England Journal of Medicine. 304(25). 1529–1533. 849 indexed citations breakdown →

14.

Shulman, Howard M., George E. Sale, K. G. Lerner, et al.. (1978). Chronic cutaneous graft-versus-host disease in man.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 91(3). 545–70. 220 indexed citations

15.

Weiden, Paul L., Rainer Storb, George E. Sale, Theodore Graham, & E. Donnall Thomas. (1978). Allogeneic hematopoietic grafts after total-body irradiation in dogs with spontaneous tumors.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 61(2). 353–7. 18 indexed citations

16.

Weiden, Paul L., R Storb, Mang-So Tsoi, H. Joachim Deeg, & T. C. Graham. (1978). Canine osteosarcoma: Results of amputation with and without adjuvant immunotherapy. Cancer Immunology Immunotherapy. 5(3). 8 indexed citations

17.

Weiden, Paul L., Rainer Storb, Sherrill J. Slichter, Reed P. Warren, & George E. Sale. (1976). Effect of Six Weekly Transfusions on Canine Marrow Grafts: Tests for Sensitization and Abrogation of Sensitization by Procarbazine and Antithymocyte Serum. The Journal of Immunology. 117(1). 143–150. 35 indexed citations

18.

Blaese, R. Michael, Paul L. Weiden, Irma R. Koski, & Nancy J. Dooley. (1974). INFECTIOUS AGAMMAGLOBULINEMIA: TRANSMISSION OF IMMUNODEFICIENCY WITH GRAFTS OF AGAMMAGLOBULINEMIC CELLS. The Journal of Experimental Medicine. 140(4). 1097–1101. 89 indexed citations

19.

Weiden, Paul L. & R. Michael Blaese. (1972). Hereditary thrombocytopenia: Relation to Wiskott-Aldrich syndrome with special reference to splenectomy. The Journal of Pediatrics. 80(2). 226–234. 30 indexed citations

20.

Weiden, Paul L., Wolfgang Epstein, & Stanley G. Schultz. (1967). Cation Transport in Escherichia coli . The Journal of General Physiology. 50(6). 1641–1661. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact